Baltimore, MDNCT06184321Now EnrollingIRB Ready

Hematopoietic and Lymphoid Cell Neoplasm Clinical Trial in Baltimore, MD

Access cutting-edge hematopoietic and lymphoid cell neoplasm treatment through this early phase 1 clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by M.D. Anderson Cancer Center

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access hematopoietic and lymphoid cell neoplasm specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hematopoietic and lymphoid cell neoplasm treatment provided free

Apply for This Baltimore Location

Check if you qualify for this hematopoietic and lymphoid cell neoplasm clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This Hematopoietic and Lymphoid Cell Neoplasm Study in Baltimore

This study investigates whether alteplase can help to improve pleural fluid drainage and dyspnea (breathlessness) in patients with non-draining malignant pleural effusion. Alteplase helps dissolve blood clots and is used to treat heart attacks, strokes, and clots in the lungs. Alteplase may help to control symptoms of breathlessness.

Sponsor: M.D. Anderson Cancer Center

Who Can Participate

Inclusion Criteria

Referral to pulmonary services for inability to drain fully via IPC
Presence of a symptomatic septated pleural effusion
A pleural effusion of significant moderate to large volume based on:
Chest radiograph: effusion filling \>= 1/3 of the hemithorax, or
Computed tomography (CT)-scan: AP depth of the effusion \>= 1/3 of the AP dimension on the axial image superior to the hemidiaphragm, including atelectatic lung surrounded by effusion, or
Ultrasound: effusion spanning at least three intercostal spaces, with a \>= 3 cm in at least one intercostal space, while the patient sits upright
Borg score \>= 3
Absence of a blocked IPC as demonstrated by a flush with 20 cc of saline x1 without resistance
Presence of septated effusion based on ultrasound (US) and chest CT

Exclusion Criteria

Inability to provide informed consent
Study subject has any disease or condition that interferes with safe completion of the study including:
Uncorrectable coagulopathy based on criteria followed by cardiopulmonary center for procedures.
Active bleeding
Known allergic reaction to thrombolytics
Pleural effusion is smaller than expected on bedside pre-procedure ultrasound
No septations and/or no loculations on bedside pre-procedure ultrasound
Patient is asymptomatic
Blocked IPC as determined by saline flush

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT06184321) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hematopoietic and Lymphoid Cell Neoplasm Treatment Options in Baltimore, MD

If you're searching for hematopoietic and lymphoid cell neoplasm treatment options in Baltimore, MD, this clinical trial (NCT06184321) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced hematopoietic and lymphoid cell neoplasm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hematopoietic and lymphoid cell neoplasm clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Baltimore, MD

See all essential tremor clinical trials recruiting in Baltimore — not just this study.

Browse Essential Tremor Trials in Baltimore →

Browse More Trials by Condition

Essential Tremor TrialsAnkylosing Spondylitis TrialsPulmonary Hypertension TrialsInterstitial Cystitis TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD